PURPOSE: To determine the potential association between genitourinary (GU) toxicity and planning dose-volume parameters for GU pelvic structures after high-dose intensity modulated radiation therapy in localized prostate cancer patients. METHODS AND MATERIALS: A total of 268 patients who underwent intensity modulated radiation therapy to a prescribed dose of 86.4 Gy in 48 fractions during June 2004-December 2008 were evaluated with the International Prostate Symptom Score (IPSS) questionnaire. Dose-volume histograms of the whole bladder, bladder wall, urethra, and bladder trigone were analyzed. The primary endpoint for GU toxicity was an IPSS sum increase ≥10 points over baseline. Univariate and multivariate analyses were done by the Kaplan-Meier method and Cox proportional hazard models, respectively. RESULTS: Median follow-up was 5 years (range, 3-7.7 years). Thirty-nine patients experienced an IPSS sum increase ≥10 during follow-up; 84% remained event free at 5 years. After univariate analysis, lower baseline IPSS sum (P=.006), the V90 of the trigone (P=.006), and the maximal dose to the trigone (P=.003) were significantly associated with an IPSS sum increase ≥10. After multivariate analysis, lower baseline IPSS sum (P=.009) and increased maximal dose to the trigone (P=.005) remained significantly associated. Seventy-two patients had both a lower baseline IPSS sum and a higher maximal dose to the trigone and were defined as high risk, and 68 patients had both a higher baseline IPSS sum and a lower maximal dose to the trigone and were defined as low risk for development of an IPSS sum increase ≥10. Twenty-one of 72 high-risk patients (29%) and 5 of 68 low-risk patients (7%) experienced an IPSS sum increase ≥10 (P=.001; odds ratio 5.19). CONCLUSIONS: The application of hot spots to the bladder trigone was significantly associated with relevant changes in IPSS during follow-up. Reduction of radiation dose to the lower bladder and specifically the bladder trigone seems to be associated with a reduction in late GU toxicity.
PURPOSE: To determine the potential association between genitourinary (GU) toxicity and planning dose-volume parameters for GU pelvic structures after high-dose intensity modulated radiation therapy in localized prostate cancerpatients. METHODS AND MATERIALS: A total of 268 patients who underwent intensity modulated radiation therapy to a prescribed dose of 86.4 Gy in 48 fractions during June 2004-December 2008 were evaluated with the International Prostate Symptom Score (IPSS) questionnaire. Dose-volume histograms of the whole bladder, bladder wall, urethra, and bladder trigone were analyzed. The primary endpoint for GU toxicity was an IPSS sum increase ≥10 points over baseline. Univariate and multivariate analyses were done by the Kaplan-Meier method and Cox proportional hazard models, respectively. RESULTS: Median follow-up was 5 years (range, 3-7.7 years). Thirty-nine patients experienced an IPSS sum increase ≥10 during follow-up; 84% remained event free at 5 years. After univariate analysis, lower baseline IPSS sum (P=.006), the V90 of the trigone (P=.006), and the maximal dose to the trigone (P=.003) were significantly associated with an IPSS sum increase ≥10. After multivariate analysis, lower baseline IPSS sum (P=.009) and increased maximal dose to the trigone (P=.005) remained significantly associated. Seventy-two patients had both a lower baseline IPSS sum and a higher maximal dose to the trigone and were defined as high risk, and 68 patients had both a higher baseline IPSS sum and a lower maximal dose to the trigone and were defined as low risk for development of an IPSS sum increase ≥10. Twenty-one of 72 high-risk patients (29%) and 5 of 68 low-risk patients (7%) experienced an IPSS sum increase ≥10 (P=.001; odds ratio 5.19). CONCLUSIONS: The application of hot spots to the bladder trigone was significantly associated with relevant changes in IPSS during follow-up. Reduction of radiation dose to the lower bladder and specifically the bladder trigone seems to be associated with a reduction in late GU toxicity.
Authors: Lars Budäus; Michel Bolla; Alberto Bossi; Cesare Cozzarini; Juanita Crook; Anders Widmark; Thomas Wiegel Journal: Eur Urol Date: 2011-10-06 Impact factor: 20.096
Authors: Akila N Viswanathan; Ellen D Yorke; Lawrence B Marks; Patricia J Eifel; William U Shipley Journal: Int J Radiat Oncol Biol Phys Date: 2010-03-01 Impact factor: 7.038
Authors: Alexander Roosen; Changhao Wu; Guiping Sui; Rasheda A Chowdhury; Pravina M Patel; Christopher H Fry Journal: Eur Urol Date: 2008-06-20 Impact factor: 20.096
Authors: Asif Harsolia; Carlos Vargas; Di Yan; Donald Brabbins; David Lockman; Jian Liang; Gary Gustafson; Frank Vicini; Alvaro Martinez; Larry L Kestin Journal: Int J Radiat Oncol Biol Phys Date: 2007-11-15 Impact factor: 7.038
Authors: Tomasz Barelkowski; Peter Wust; David Kaul; Sebastian Zschaeck; Waldemar Wlodarczyk; Volker Budach; Pirus Ghadjar; Marcus Beck Journal: Strahlenther Onkol Date: 2019-12-23 Impact factor: 3.621
Authors: Kazuma Kobayashi; Naoya Murakami; Kana Takahashi; Koji Inaba; Hiroshi Igaki; Ryuji Hamamoto; Jun Itami Journal: In Vivo Date: 2021 Jan-Feb Impact factor: 2.155
Authors: Thomas P Kole; Michael Tong; Binbin Wu; Siyuan Lei; Olusola Obayomi-Davies; Leonard N Chen; Simeng Suy; Anatoly Dritschilo; Ellen Yorke; Sean P Collins Journal: Acta Oncol Date: 2015-05-14 Impact factor: 4.089
Authors: Maria Thor; Caroline Olsson; Jung Hun Oh; Stine Elleberg Petersen; David Alsadius; Lise Bentzen; Niclas Pettersson; Ludvig Paul Muren; Morten Høyer; Gunnar Steineck; Joseph O Deasy Journal: Radiother Oncol Date: 2016-02-12 Impact factor: 6.280
Authors: Sangkyu Lee; Sarah Kerns; Harry Ostrer; Barry Rosenstein; Joseph O Deasy; Jung Hun Oh Journal: Int J Radiat Oncol Biol Phys Date: 2018-01-31 Impact factor: 7.038
Authors: A Zapatero; M Roch; D Büchser; P Castro; L Fernández-Banda; G Pozo; O Liñán; C Martin de Vidales; A Cruz-Conde; F García-Vicente Journal: Clin Transl Oncol Date: 2017-04-03 Impact factor: 3.405
Authors: Maria Thor; Joseph O Deasy; Rebecca Paulus; W Robert Lee; Mahul B Amin; Deborah W Bruner; Daniel A Low; Amit B Shah; Shawn C Malone; Jeff M Michalski; Ian S Dayes; Samantha A Seaward; Elizabeth M Gore; Michele Albert; Thomas M Pisansky; Sergio L Faria; Yuhchyau Chen; Bridget F Koontz; Gregory P Swanson; Stephanie L Pugh; Howard M Sandler Journal: Radiother Oncol Date: 2019-03-05 Impact factor: 6.280
Authors: Lara Hathout; Michael R Folkert; Marisa A Kollmeier; Yoshiya Yamada; Gil'ad N Cohen; Michael J Zelefsky Journal: Int J Radiat Oncol Biol Phys Date: 2014-10-01 Impact factor: 7.038